Lipid management reduces cardiovascular complications in individuals with diabetes and prediabetes.

Preventive cardiology

Volumn 9, Issue 2, 2006, Pages

  Gosavi, Aparna ^a   Flaker, Gregory ^a   Gardner, David ^a  

^a University of Missouri   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTILIPEMIC AGENT;

CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CORONARY ARTERY ATHEROSCLEROSIS; DRUG EFFECT; DYSLIPIDEMIA; GLUCOSE BLOOD LEVEL; HUMAN; HYPERGLYCEMIA; INSULIN RESISTANCE; METABOLISM; NON INSULIN DEPENDENT DIABETES MELLITUS; PATHOPHYSIOLOGY; RANDOMIZED CONTROLLED TRIAL; REVIEW;

ANTILIPEMIC AGENTS; BLOOD GLUCOSE; CORONARY ARTERIOSCLEROSIS; DIABETES MELLITUS, TYPE 2; DYSLIPIDEMIAS; HUMANS; HYPERGLYCEMIA; INSULIN RESISTANCE; RANDOMIZED CONTROLLED TRIALS;

EID: 33745349891     PISSN: 1520037X     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1520-037x.2000.4071.x     Document Type: Review

References (29)